Abstracts tagged "Complementary alternative medicine"

Abstract Number: 2796 • 2019 ACR/ARP Annual Meeting
The Association Between Omega-3 Supplementation and Disease Activity in a Rheumatoid Arthritis (RA) Observational Cohort
Adel Andemeskel¹, Vivi Feathers ¹, Christine Iannaccone ¹, Jing Cui ¹ and Nancy Shadick ¹, ¹Brigham and Women's Hospital, Boston, MA
Background/Purpose: Omega-3 supplementation is one of a few complementary and alternative medicine (CAM) therapies that has shown promise in improving RA symptoms through small, randomized…
Abstract Number: 992 • 2018 ACR/ARHP Annual Meeting
Epigallocatechin-3-Gallate (EGCG) Suppresses Systemic Inflammation By Inhibiting IL-6-Induced STAT3 Activation in Cultured Hepatocytes and in Liver Tissue of Adjuvant-Induced Arthritis (AIA) Rats
Anil K. Singh¹, Sabrina Fechtner², Dorothy Wang², Mukesh Chourasia³ and Salahuddin Ahmed^2,4, ¹Washington State University, College of Pharmacy, Spokane, WA, ²Department of Pharmaceutical Sciences, Washington State University, College of Pharmacy, Spokane, WA, ³Department of Pharmacoinformatics,, National lnstitute of Pharmaceutical Education and Research, Hajipur,, India, ⁴Division of Rheumatology, University of Washington, Division of Rheumatology, School of Medicine, Seattle, WA
Background/Purpose: In rheumatoid arthritis (RA), the pro-inflammatory cytokine interleukin-6 (IL-6) induces systemic inflammation by activating hepatocytes through IL-6 receptor (IL-6R)- mediated JAK/STAT3 signaling pathway. The…
Abstract Number: 2545 • 2018 ACR/ARHP Annual Meeting
Use of Oral Complementary Medicine in Inflammatory Arthritis: Data from the Australian Rheumatology Association Database (ARAD)
Ashley Fletcher^1,2, Margaret P. Staples^3,4, Catherine Hill^5,6,7, Marissa Lassere⁸, Lyn March^9,10,11,12, Graeme Carroll¹³, Claire Barrett¹⁴, Vibhasha Chand⁴ and Rachelle Buchbinder^4,15, ¹Monash Department of Clinical Epidemiology, Cabrini Institute, Melbourne, Australia, ²Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia, ³Monash Department of Clinical Epidemiology, Cabrini Institute, Malvern, Australia, ⁴Monash University, Melbourne, Australia, ⁵The Queen Elizabeth Hospital, Adelaide, Australia, ⁶Rheumatology Unit, Royal Adelaide Hospital, Adelaide, Australia, ⁷Medicine, The University of Adelaide, Adelaide, Australia, ⁸University of New South Wales, Sydney, Australia, ⁹Department of Rheumatology, Northern Clinical School, Institute of Bone and Joint Research, Kolling Institute, University of Sydney & Department of Rheumatology, Royal North Shore Hospital, St Leonards, Sydney, Australia, ¹⁰Institute of Bone and Joint Research, University of Sydney, Sydney, Australia, ¹¹Rheumatology, Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, Australia, ¹²Rheumatology, University of Sydney, Insitute of Bone and Joint Research, Royal North Shore Hospital, St Leonards NSW, Australia, ¹³Adult Rheumatology and Osteoarthritis, University of Notre Dame, Mount Lawley WA, Australia, ¹⁴Redcliffe Hospital, University of Queensland, Redcliffe, Australia, ¹⁵Cabrini Institute, Victoria, Australia
Background/Purpose: To describe the use of oral complementary medicine (CM) in people with inflammatory arthritis. Methods: The Australian Rheumatology Association Database (ARAD), an observational database,…
Abstract Number: 343 • 2017 ACR/ARHP Annual Meeting
What Is the Impact of Functional Medicine on Patient Reported Outcomes in Inflammatory Arthritis?
Nicole Droz¹, William Messner² and M. Elaine Husni³, ¹Rheumatology, Cleveland Clinic Foundation, Cleveland, OH, ²Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, ³Rheumatology, Cleveland Clinic, Cleveland, OH
Background/Purpose: Both RA and PsA patients carry significant morbidity despite advances in treatment. Patients often do not achieve clinical remission which can be limited by…
Abstract Number: 311 • 2016 ACR/ARHP Annual Meeting
Comparative Effectiveness of Ayurveda and Conventional Care in Knee Osteoarthritis – a Randomized Controlled Trial
Christian Kessler^1,2, Kartar Dhiman³, Abhimanyu Kumar⁴, Thomas Ostermann⁵, Shivenarain Gupta^6,7, Antonio Morandi⁸, Martin Mittwede^7,9, Elmar Stapelfeldt², Michaela Spoo², Katja Icke¹, Andreas Michalsen^1,2 and Claudia Witt^1,10, ¹Institute for Social Medicine, Epidemiology and Health Economics, Charité University Medical Center, Berlin, Germany, ²Department for Complementary Medicine, Immanuel Hospital Berlin, Berlin, Germany, ³Central Council for Research in Ayurvedic Sciences (CCRAS), New Delhi, India, New Delhi, India, ⁴All India Institute of Ayurveda, New Delhi, India, ⁵Department of Psychology and Psychotherapy, University of Witten Herdeckey, Witten, Germany, ⁶Department of Kaya Cikitsa, J.S. Ayurveda College & P.D. Patel Ayurveda Hospital, Nadiad, India, ⁷European Academy of Ayurveda, Birstein, Germany, ⁸Ayurvedic Point, School of Ayurvedic Medicine, Milan, Italy, ⁹Department of Theology and Religious Sciences, University of Frankfurt, Frankfurt, Germany, ¹⁰Institute of Complementary and Integrative Medicine, University Hospital and University of Zurich, Zürich, Switzerland
Background/Purpose: Ayurveda is used to treat knee osteoarthritis (OA) despite limited evidence. We aimed to evaluate the effectiveness of complex multimodality Ayurvedic treatment in comparison…
Abstract Number: 2232 • 2014 ACR/ARHP Annual Meeting
Cost-Effectiveness of Glucosamine, Chondroitin Sulfate, Their Combination, Celecoxib,Non-Selective Non-Steroidal Anti-Inflammatory Drugs, and Placebo in Treating Knee Osteoarthritis
Vishvas Garg¹, Dennis Raisch², Ning Yan Gu³, Matthew E Borrego³ and Daniel O. Clegg⁴, ¹College of Pharmacy, University of New Mexico (at the time of research), Grayslake, IL, ²College of Pharmacy, University of New Mexico, Albuquerque, NM, ³University of New Mexico, Albuquerque, NM, ⁴Rheumatology, George Wahlen VA Medical Center/University of Utah, Salt Lake City, UT
Background/Purpose: Knee osteoarthritis (KOA) affects 13.8% of the US population aged ≥26, causing significant burden-of-illness. We compared the cost-effectiveness of conventional medicines such as non-steroidal…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].